Results 21 to 30 of about 58,747 (290)

Engineering organoids [PDF]

open access: yesNature Reviews Materials, 2021
Organoids are in vitro miniaturized and simplified model systems of organs that have gained enormous interest for modelling tissue development and disease, and for personalized medicine, drug screening and cell therapy. Despite considerable success in culturing physiologically relevant organoids, challenges remain to achieve real-life applications.
Moritz Hofer, Matthias P. Lutolf
openaire   +2 more sources

Organoids and Colorectal Cancer [PDF]

open access: yesCancers, 2021
Organoids were first established as a three-dimensional cell culture system from mouse small intestine. Subsequent development has made organoids a key system to study many human physiological and pathological processes that affect a variety of tissues and organs. In particular, organoids are becoming very useful tools to dissect colorectal cancer (CRC)
Antonio Barbáchano   +6 more
openaire   +5 more sources

Organoid

open access: yes, 2021
Henk ten Have   +1 more
core   +6 more sources

Kras in Organoids [PDF]

open access: yesCold Spring Harbor Perspectives in Medicine, 2018
Oncogenic Kras are genetic dependencies for the majority of pancreatic and colorectal adenocarcinomas; however, much remains to be understood regarding its tropism to these carcinomas. Recently developed organoid technology presents a more representative model culture system for pancreatic and colon epithelial tissues as well as better fostering the ...
Derek, Cheng, David, Tuveson
openaire   +2 more sources

Recent advances and challenges in organoid-on-a-chip technology

open access: yes, 2022
Conventional 2-dimensional cell culture poorly mimics human-relevant models, which is considered a major challenge in biological research. Organoids are a recent breakthrough in 3-dimensional (3D) in vitro tissue engineering that better reflect the ...
Tae-Hyung Kim, Intan Rosalina Suhito
core   +1 more source

Trends in the global organoid technology and industry: from organogenesis in a dish to the commercialization of organoids

open access: yes, 2021
Animal models have been standard methods for non-clinical research in drug development for decades. However, many drugs that have shown satisfactory results in non-clinical studies have failed in the clinical stage, presumably because animal data are not
Dong-Hun Woo   +3 more
core   +1 more source

Glioblastoma organoid technology: an emerging preclinical models for drug discovery

open access: yes, 2022
Glioblastoma multiforme (GBM) is the most prevalent type of primary brain tumor among adults, and it has a median overall survival of 12 to 15 months upon diagnosis.
Shuchang Zhou   +3 more
core   +1 more source

Small molecule-induced destabilization of β-catenin and RAS is the ideal strategies for suppressing colorectal cancer [PDF]

open access: yesOrganoid, 2023
Background Mutations of adenomatous polyposis coli (APC) and KRAS play essential roles in the development of colorectal cancer (CRC) by forming an abnormal colon morphology.
Yonghyo Kim   +3 more
doaj   +1 more source

Progress, prospects, and limitations of organoid technology

open access: yes, 2022
Organoids are mini-organs generated through in vitro 3-dimensional culture that mimic some of the structural and physiological functions of real organs.
Jung Kyu Choi   +2 more
core   +1 more source

Tumor spheroid-based and microtumor-based vascularized models for replicating the vascularized tumor microenvironment [PDF]

open access: yesOrganoid, 2023
Background Tumor vasculature is a crucial pathway for supplying nutrients and oxygen to tumors during their progression, as well as facilitating the delivery of anticancer drugs or immunotherapeutic agents.
Jiyoung Song   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy